Sold out of itself: management is turning demand away today because the company cannot supply it, and the fix is already
The model's full reasoning — Q1 2018 call → NOWe need answer YES or NO based on transcript. Need determine if management describes currently failing to serve demand it already has, material, and already acting to close gap. Transcript: Q1 2018 Illumina. They discuss strong growth. NovaSeq rollout. They mention iSeq platform launched, beta testing, identified opportunities to improve corporate billing and shipping processes, validating improvements, expect to scale shipments midyear. "we continue to see strong interest in iSeq and are approaching 100 orders." Is that demand unserved? They have beta units only, not scaled shipments. They are in process of validating improvements, expect to scale shipments midyear. That suggests they have demand (orders) but not shipping due to improvements. But is it material? Approaching 100 orders, likely small relative to company. Also not described as significant. Also they are acting to fix. But material? No. Any other? NovaSeq shipments down sequentially as expected, no mention of inability to supply. Sequencing consumables strong. Microarrays strong. No mention of buyers turned away. No capacity constraints. They mention "we are in process of validating improvements and expect to scale shipments midyear" for iSeq. That is a delay, but not material? Let's inspect. The question asks ONE coherent present-tense situation with all three. iSeq: demand already there? "approaching 100 orders" but not yet shipped? They shipped units for beta testing. They identified improvements to corporate billing and shipping processes. That is not inability to supply due to capacity, but product robustness/reliability. They are "in the process of validating these improvements" and "expect to scale shipments midyear." So current unserved demand? They have orders but not shipped. However, management does not describe as material. 100 orders is trivial. Also no mention that serving it would leave company visibly larger. So NO. Any other? NovaSeq consumables growth, no constraints. They talk about "NovaSeq upgrade cycle will span multiple years" not supply constraint. No mention of backlog or allocation. No mention of lead times. So answer NO. Need final only YES or NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| ZBH | Zimmer Biomet Holdings, Inc. | Q2 2017 | 2017-07-30 | F |
OGI · Q3 2022 → YESThe question is: Does management describe that the company is CURRENTLY FAILING TO SERVE DEMAND IT ALREADY HAS — real buyers being turned away, etc., because they can't supply, AND already spending or...YES The transcript shows management describing a current situation where demand is outstripping supply ("we have been really tight on our supply. Our demand was outstripping our supply"), leading to turning away or limiting sales to certain provinces ("we were really stealing from 1 pocket to the other as we're trying to balance the demand to what available capacity we had" and limiting SHRED distribution). This is material, as it affects their ability to serve existing customers fully.
CRL · Q2 2022 → YESThe question is whether management describes the company currently failing to serve demand it already has, and already spending or committing to remove that limit. YES The transcript shows clients securing space in take-or-pay arrangements because of tight capacity, indicating unserved demand from existing buyers. Management notes capacity is well utilized and they are hiring staff to accommodate higher forecasted demand, confirming they are already acting to close the gap. This situation is material given the backlog growth and emphasis on availability over price.
BRBR · Q4 2023 → YESThe question is whether management describes the company currently failing to serve demand it already has, and already spending or committing to remove that limit. NO The transcript shows ongoing capacity constraints and tight supply dynamics, with management noting they are holding back on marketing/promotions due to limited supply and that they lost customers in prior years due to capacity.